| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/2004 | WO2002043771A9 Conjugates of glycosylated/galactosylated peptide |
| 04/29/2004 | WO2001095899A8 Pharmaceutical compositions comprising cannabidiol derivatives |
| 04/29/2004 | WO1999028440A9 Nucleic acid encoding mammalian ubr1 |
| 04/29/2004 | WO1994004185A3 Method of inhibiting reduction of disulfide bonds |
| 04/29/2004 | WO1991000348A3 Modified vp1/p2a regions of the rhinoviral system |
| 04/29/2004 | US20040083447 1-Phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands |
| 04/29/2004 | US20040082934 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 04/29/2004 | US20040082807 Novel salt forms of poorly soluble probucol esters and ethers |
| 04/29/2004 | US20040082805 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents |
| 04/29/2004 | US20040082802 26,27-Homologated-20-EPI-2-alkyl-19-nor-vitamin D compounds |
| 04/29/2004 | US20040082798 Novel amino dicarboxylic acid derivatives with pharmaceutical properties |
| 04/29/2004 | US20040082796 Reacting a substituted benzonitrile with a cysteine compound |
| 04/29/2004 | US20040082791 Crystals of benzimidazole compounds |
| 04/29/2004 | US20040082790 Piperidine amides as modulators of chemokine receptor activity |
| 04/29/2004 | US20040082789 Thieno[2,3-c]iosquinolines for use as inhibitors of parp |
| 04/29/2004 | US20040082788 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 04/29/2004 | US20040082787 Chemical compounds |
| 04/29/2004 | US20040082783 Bis (amino acid) molecular scaffolds |
| 04/29/2004 | US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/29/2004 | US20040082667 Hangover treatment |
| 04/29/2004 | US20040082666 Antiserotonine agents |
| 04/29/2004 | US20040082665 Using 1,7,7- trimethylbicyclo(2.2.1)heptane |
| 04/29/2004 | US20040082664 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 04/29/2004 | US20040082663 Imidazoline receptor binding compounds |
| 04/29/2004 | US20040082661 Urea derivatives having vanilloid receptor (vr1) antagonist activity |
| 04/29/2004 | US20040082660 Using latanoprost |
| 04/29/2004 | US20040082659 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
| 04/29/2004 | US20040082658 Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 04/29/2004 | US20040082657 Composition for suppressing the appetite of a human being comprising L-theanine and method of administering same |
| 04/29/2004 | US20040082656 Higher unsaturated fatty acid composition |
| 04/29/2004 | US20040082655 Method of treating musculoskeletal and connective tissue inflammations |
| 04/29/2004 | US20040082654 Mixture of menthyl lactate and triethyl citrate; stable freshness; deodorizing; hygiene; disposable product |
| 04/29/2004 | US20040082653 Using prostaglandin antagonist |
| 04/29/2004 | US20040082652 Nitric ester derivatives and their use in treating gastrointestinal tumors |
| 04/29/2004 | US20040082648 Fermentation of a culture product; drug, antiseptics; antibiotic resistant infections |
| 04/29/2004 | US20040082647 Anticholesterol agents; controlling bile acid transfer into intestines |
| 04/29/2004 | US20040082646 Hypotensive agents; antiischemic agents; antiarrhythmia agents |
| 04/29/2004 | US20040082644 Synergistic mixture of acetylcholinesterase inhibitor and anticholinergic agent; side effect reduction |
| 04/29/2004 | US20040082643 Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus |
| 04/29/2004 | US20040082642 Novel estrogen receptor ligands and method III |
| 04/29/2004 | US20040082641 Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases |
| 04/29/2004 | US20040082640 Use of cox-2 inhibitors for preventing immunodeficiency |
| 04/29/2004 | US20040082638 Compounds, compositions and methods |
| 04/29/2004 | US20040082637 Heterocyclic topoisomerase poisons |
| 04/29/2004 | US20040082636 Method for the prophylaxis or treatment of glomerulonephritis |
| 04/29/2004 | US20040082635 Fused cyclic compounds and medicinal use thereof |
| 04/29/2004 | US20040082634 Using allantoin; skin disorders, antiulcer agents, antiinflammatory agents |
| 04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
| 04/29/2004 | US20040082630 1g(a)-Amino-n-hydroxy-acetamide derivatives |
| 04/29/2004 | US20040082626 Cyclic compounds exhibiting thrombopoietin receptor agonism |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082624 Organic compounds |
| 04/29/2004 | US20040082623 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/29/2004 | US20040082622 N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 04/29/2004 | US20040082621 Composition comprising 5-[4-[2-(N-methyl-N-2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione |
| 04/29/2004 | US20040082620 Antidiabetic agents |
| 04/29/2004 | US20040082618 Liquid dosage forms of acid labile drugs |
| 04/29/2004 | US20040082617 Sulphones which modulate the action of gamma secretase |
| 04/29/2004 | US20040082616 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; antiarthritic agents |
| 04/29/2004 | US20040082614 Chlamydia infections; anticholesterol agents; cardiovascular disorders; using mixture containing azithromycin |
| 04/29/2004 | US20040082613 Modulators of Cdk9 as a therapeutic target in cardiac hypertrophy |
| 04/29/2004 | US20040082609 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 04/29/2004 | US20040082608 Active oxygen scavenger |
| 04/29/2004 | US20040082606 Excitatory amino acid receptor antagonists |
| 04/29/2004 | US20040082605 Use |
| 04/29/2004 | US20040082604 Antiarthritic agents; osteoporosis; immunosuppressants; antiinflammatory agents; autoimmunology diseases |
| 04/29/2004 | US20040082603 2,3-Dihydro-isoindol-1-one derivatives |
| 04/29/2004 | US20040082602 Kinase inhibitor; analgesics; antiarthritic agents; antihistamines; gastrointestinal disorders |
| 04/29/2004 | US20040082601 Anti-inflammatory compounds |
| 04/29/2004 | US20040082600 Bioavailability; oral administering; cardiovascular disorders; sexual disorders |
| 04/29/2004 | US20040082597 Use of CRF antagonists and related compositions |
| 04/29/2004 | US20040082596 Novel carbamate-substituted pyrazolopyridine derivatives |
| 04/29/2004 | US20040082595 Antiproliferative agents; antitumor agents; cyclin-dependent kinase inhibitor |
| 04/29/2004 | US20040082594 Novel uses of combined 5-ht 1a agonists and serotonin reuptake inhibitors |
| 04/29/2004 | US20040082593 Mixing with aqueous solution containing sulfuric acid or sodium bisulfate; stabilization |
| 04/29/2004 | US20040082592 Metabotropic glutamate receptor antagonists |
| 04/29/2004 | US20040082590 Dietetics; antidiabetic agents; sexual disorders |
| 04/29/2004 | US20040082589 Quinoline derivatives as nk-3 and nk-2 antagonists |
| 04/29/2004 | US20040082588 Controlling concentration of calcium in blood |
| 04/29/2004 | US20040082584 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 04/29/2004 | US20040082583 Chemical compounds |
| 04/29/2004 | US20040082582 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/29/2004 | US20040082581 Controlling cell proliferation; antitumor agents |
| 04/29/2004 | US20040082580 Autoimmune diseases; antiinflammatory agents |
| 04/29/2004 | US20040082579 Substituted-4-quinolones |
| 04/29/2004 | US20040082578 Antiinflammatory agents; Aids therapy; phosphodiesterase inhibitor |
| 04/29/2004 | US20040082576 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/29/2004 | US20040082575 Compounds and methods for modulation of estrogen receptors |
| 04/29/2004 | US20040082574 Compounds with the bicyclo[4.2.1]nonane system for the treatment of flavivridae infections |
| 04/29/2004 | US20040082573 Anxiolytic agents with reduced sedative and ataxic effects |
| 04/29/2004 | US20040082572 Benzodiazepine derivatives as app modulators |
| 04/29/2004 | US20040082569 Novel substituted amides, their preparation and use |
| 04/29/2004 | US20040082568 Tetrazolylpropionamides as inhibitors of Abeta protein production |
| 04/29/2004 | US20040082567 Antiproliferative agents; anticancer agents; fungicides; antiinflammatory agents |
| 04/29/2004 | US20040082566 Pyrrolidine sulfonamides |
| 04/29/2004 | US20040082565 Formulations and methods of administration of cephalotaxines including homoharringtonine |
| 04/29/2004 | US20040082564 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 04/29/2004 | US20040082563 Thrombosis therapy; antitumor agents; anticoagulants; Factor x inhibitors; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
| 04/29/2004 | US20040082562 Novel inhibitors of IMPDH enzyme |
| 04/29/2004 | US20040082559 Vitronectin receptor antagonists |